書誌情報
O1-4. LONG-TERM SAFETY & EFFICACY OF ELOTUZUMAB IN RELAPSED / REFRACTORY MULTIPLE MYELOMA : JAPAN PH1 STUDY
Hirokazu Nagai1, Takaaki Chou2, Gen Kinoshita3, Masafumi Miyoshi3, Shinsuke Iida4
1Department of Hematology, National Hospital Organization Nagoya Medical Center, 2Niigata Cancer Center Hospital, 3Bristol-Myers Squibb K.K., 4Nagoya City University Graduate School of Medical Sciences
International Journal of Myeloma 8(2): 99-99, 2018.
個人会員・法人会員の方（IDが5または10で始まる方）
- 全文ダウンロード： 従量制、基本料金制の方共に121円(税込) です。
